{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T01:49:59Z","timestamp":1790732999606,"version":"4.1.0"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,19]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Improved epidemiologic and treatment data for active tuberculosis (TB) with chronic hepatitis B virus (cHBV) infection might inform and encourage screening and vaccination programs focused on persons at risk of having both conditions.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We matched the California Department of Public Health TB registry during 2016\u20132020 to the cHBV registry using probabilistic matching algorithms. We used chi-square analysis to compare the characteristics of persons with TB and cHBV with those with TB only. We compared TB treatment outcomes between these groups using modified Poisson regression models. We calculated the time between reporting of TB and cHBV diagnoses for those with both conditions.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We identified 8435 persons with TB, including 316 (3.7%) with cHBV. Among persons with TB and cHBV, 256 (81.0%) were non\u2013US-born Asian versus 4186 (51.6%) with TB only (P &amp;lt; .0001). End-stage renal disease (26 [8.2%] vs 322 [4.0%]; P &amp;lt; .001) and HIV (21 [6.7%] vs 247 [3.0%]; P = .02) were more frequent among those with TB and cHBV compared with those with TB only. Among those with both conditions, 35 (11.1%) had TB diagnosed &amp;gt;60 days before cHBV (median, 363 days) and 220 (69.6%) had TB diagnosed &amp;gt;60 days after cHBV (median, 3411 days).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Persons with TB and cHBV were found more frequently in certain groups compared with TB only, and infrequently had their conditions diagnosed together. This highlights an opportunity to improve screening and treatment of TB and cHBV in those at high risk for coinfection.<\/jats:p><\/jats:sec>","DOI":"10.1093\/cid\/ciae169","type":"journal-article","created":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T23:04:03Z","timestamp":1711407843000},"page":"223-232","source":"Crossref","is-referenced-by-count":4,"title":["Epidemiology and Treatment Outcomes of Tuberculosis With Chronic Hepatitis B Infection\u2014California, 2016\u20132020"],"prefix":"10.1093","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1521-0276","authenticated-orcid":false,"given":"J Bradford","family":"Bertumen","sequence":"first","affiliation":[{"name":"Centers for Disease Control and Prevention , Epidemic Intelligence Service, Atlanta, Georgia , USA"},{"name":"California Department of Public Health , Division of Communicable Disease Control, Richmond, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Pascopella","sequence":"additional","affiliation":[{"name":"California Department of Public Health , Division of Communicable Disease Control, Richmond, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Han","sequence":"additional","affiliation":[{"name":"California Department of Public Health , Division of Communicable Disease Control, Richmond, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosie","family":"Glenn-Finer","sequence":"additional","affiliation":[{"name":"California Department of Public Health , Division of Communicable Disease Control, Richmond, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J","family":"Wong","sequence":"additional","affiliation":[{"name":"Stanford University School of Medicine , Department of Medicine\/Gastroenterology and Hepatology, Palo Alto, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Chitnis","sequence":"additional","affiliation":[{"name":"Alameda County Public Health Department, Tuberculosis Section\/Division of Communicable Disease Control and Prevention , San Leandro, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devan","family":"Jaganath","sequence":"additional","affiliation":[{"name":"University of California, San Francisco School of Medicine , Center for Tuberculosis, San Francisco, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirna","family":"Jewell","sequence":"additional","affiliation":[{"name":"Los Angeles County Public Health Department , Communicable Disease Control and Prevention Division, Los Angeles, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prabhu","family":"Gounder","sequence":"additional","affiliation":[{"name":"Los Angeles County Public Health Department , Communicable Disease Control and Prevention Division, Los Angeles, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"McElroy","sequence":"additional","affiliation":[{"name":"California Department of Public Health , Division of Communicable Disease Control, Richmond, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Stockman","sequence":"additional","affiliation":[{"name":"California Department of Public Health , Division of Communicable Disease Control, Richmond, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2962-1890","authenticated-orcid":false,"given":"Pennan","family":"Barry","sequence":"additional","affiliation":[{"name":"California Department of Public Health , Division of Communicable Disease Control, Richmond, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,3,26]]},"reference":[{"key":"2024071918140234400_ciae169-B1"},{"key":"2024071918140234400_ciae169-B2","author":"World Health Organization"},{"key":"2024071918140234400_ciae169-B3","doi-asserted-by":"crossref","first-page":"297","DOI":"10.15585\/mmwr.mm7212a1","article-title":"Tuberculosis\u2014United States, 2022","volume":"72","author":"Schildknecht","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2024071918140234400_ciae169-B4","author":"California Department of Public Health"},{"key":"2024071918140234400_ciae169-B5","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1007\/s10903-021-01231-6","article-title":"Epidemiology and prevention of tuberculosis and chronic hepatitis B virus infection in the United States","volume":"23","author":"Chitnis","year":"2021","journal-title":"J Immigr Minor Health"},{"key":"2024071918140234400_ciae169-B6","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1007\/s10620-021-07056-5","article-title":"Prevalence of latent tuberculosis infection among persons with chronic hepatitis B virus infection: a systematic review and meta-analysis","volume":"67","author":"Chen","year":"2022","journal-title":"Dig Dis Sci"},{"key":"2024071918140234400_ciae169-B7","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S1473-3099(16)30216-X","article-title":"The cascade of care in diagnosis and treatment of latent tuberculosis infection: a systematic review and meta-analysis","volume":"16","author":"Alsdurf","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"2024071918140234400_ciae169-B8","doi-asserted-by":"crossref","first-page":"331","DOI":"10.37765\/ajmc.2020.44069","article-title":"The hepatitis B care cascade using administrative claims data, 2016","volume":"26","author":"Harris","year":"2020","journal-title":"Am J Manag Care"},{"key":"2024071918140234400_ciae169-B9","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1007\/s10903-022-01364-2","article-title":"Screening practices for latent tuberculosis infection in clinical trials evaluating treatments for chronic hepatitis B virus infection","volume":"24","author":"Le","year":"2022","journal-title":"J Immigr Minor Health"},{"key":"2024071918140234400_ciae169-B10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7201a1","article-title":"Screening and testing for hepatitis B virus infection: CDC recommendations\u2014United States, 2023","volume":"72","author":"Conners","year":"2023","journal-title":"MMWR Recomm Rep"},{"key":"2024071918140234400_ciae169-B11","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw694","article-title":"Official American Thoracic Society\/Infectious Diseases Society of America\/Centers for Disease Control and Prevention Clinical Practice Guidelines: diagnosis of tuberculosis in adults and children","volume":"64","author":"Lewinsohn","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2024071918140234400_ciae169-B12","author":"Centers for Disease Control and Prevention"},{"key":"2024071918140234400_ciae169-B13","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10096-004-1272-8","article-title":"High prevalence of hepatitis B virus infection among tuberculosis patients with and without HIV in Rio de Janeiro, Brazil","volume":"24","author":"Blal","year":"2005","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2024071918140234400_ciae169-B14","doi-asserted-by":"crossref","first-page":"8920","DOI":"10.3748\/wjg.v21.i29.8920","article-title":"Viral hepatitis prevalence in patients with active and latent tuberculosis","volume":"21","author":"Nooredinvand","year":"2015","journal-title":"World J Gastroenterol"},{"key":"2024071918140234400_ciae169-B15","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1017\/S0950268814002970","article-title":"Characteristics and TB treatment outcomes in TB patients with viral hepatitis, New York City, 2000\u20132010","volume":"143","author":"Bushnell","year":"2015","journal-title":"Epidemiol Infect"},{"key":"2024071918140234400_ciae169-B16","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/PHH.0000000000001536","article-title":"Prevalence of hepatitis B virus and latent tuberculosis coinfection in the United States","volume":"28","author":"Wong","year":"2022","journal-title":"J Public Health Manag Pract"},{"key":"2024071918140234400_ciae169-B17","first-page":"e14433","article-title":"Co-infection with hepatitis B in tuberculosis patients on anti-tuberculosis treatment and the final outcome","volume":"13","author":"Khan","year":"2021","journal-title":"Cureus"},{"key":"2024071918140234400_ciae169-B18","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1186\/s12879-018-3192-8","article-title":"Co-infection with hepatitis B virus among tuberculosis patients is associated with poor outcomes during anti-tuberculosis treatment","volume":"18","author":"Chen","year":"2018","journal-title":"BMC Infect Dis"},{"key":"2024071918140234400_ciae169-B19","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1111\/jvh.13751","article-title":"Risk of drug-induced liver injury in chronic hepatitis B and tuberculosis co-infection: a systematic review and meta-analysis","volume":"29","author":"Chou","year":"2022","journal-title":"J Viral Hepat"},{"key":"2024071918140234400_ciae169-B20","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.5588\/ijtld.18.0195","article-title":"The role of chronic viral hepatitis on tuberculosis treatment interruption","volume":"22","author":"Chua","year":"2018","journal-title":"Int J Tuberc Lung Dis"},{"key":"2024071918140234400_ciae169-B21","author":"Mejia"},{"key":"2024071918140234400_ciae169-B22","doi-asserted-by":"crossref","first-page":"1900655","DOI":"10.1183\/13993003.00655-2019","article-title":"The global prevalence of latent tuberculosis: a systematic review and meta-analysis","volume":"54","author":"Cohen","year":"2019","journal-title":"Eur Respir J"},{"key":"2024071918140234400_ciae169-B23","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/hep.31782","article-title":"An updated assessment of chronic hepatitis B prevalence among foreign-born persons living in the United States","volume":"74","author":"Wong","year":"2021","journal-title":"Hepatology"},{"key":"2024071918140234400_ciae169-B24","author":"Council of State and Territorial Epidemiologists"},{"key":"2024071918140234400_ciae169-B25","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/hep.30831","article-title":"Chronic hepatitis B prevalence among foreign-born and U.S.-born adults in the United States, 1999\u20132016","volume":"71","author":"Le","year":"2020","journal-title":"Hepatology"},{"key":"2024071918140234400_ciae169-B26"},{"key":"2024071918140234400_ciae169-B27","author":"Centers for Disease Control and Prevention"},{"key":"2024071918140234400_ciae169-B28","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1017\/ice.2018.219","article-title":"Epidemiology, detection, and management of tuberculosis among end-stage renal disease patients","volume":"39","author":"Okada","year":"2018","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2024071918140234400_ciae169-B29","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1080\/17512433.2019.1657828","article-title":"Hepatitis B virus infection as a risk factor for chronic kidney disease","volume":"12","author":"Fabrizi","year":"2019","journal-title":"Expert Rev Clin Pharmacol"},{"key":"2024071918140234400_ciae169-B30","doi-asserted-by":"crossref","first-page":"e13259","DOI":"10.1111\/ctr.13259","article-title":"Mycobacterium tuberculosis after solid organ transplantation: a review of more than 2000 cases","volume":"32","author":"Abad","year":"2018","journal-title":"Clin Transplant"},{"issue":"6","key":"2024071918140234400_ciae169-B31","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.TNMI7-0026-2016","article-title":"Biologic agents and tuberculosis","volume":"4","author":"Dobler","year":"2016","journal-title":"Microbiol Spectr"},{"key":"2024071918140234400_ciae169-B32","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1053\/j.gastro.2017.02.009","article-title":"Hepatitis B reactivation associated with immune suppressive and biological modifier therapies: current concepts, management strategies, and future directions","volume":"152","author":"Loomba","year":"2017","journal-title":"Gastroenterology"},{"key":"2024071918140234400_ciae169-B33","author":"Centers for Disease Control and Prevention"},{"key":"2024071918140234400_ciae169-B34","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1164\/rccm.200510-1666ST","article-title":"An official ATS statement: hepatotoxicity of antituberculosis therapy","volume":"174","author":"Saukkonen","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"2024071918140234400_ciae169-B35","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1093\/cid\/ciz241","article-title":"Antiviral therapy for hepatitis B prevents liver injury in patients with tuberculosis and hepatitis B coinfection","volume":"70","author":"Lui","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2024071918140234400_ciae169-B36","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1002\/hep.31991","article-title":"Prevalence of HBV infection, vaccine-induced immunity, and susceptibility among at-risk populations: US households, 2013\u20132018","volume":"74","author":"Roberts","year":"2021","journal-title":"Hepatology"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciae169\/57799738\/ciae169.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/79\/1\/223\/58600043\/ciae169.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/79\/1\/223\/58600043\/ciae169.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T00:49:50Z","timestamp":1731631790000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/79\/1\/223\/7635456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,26]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,3,26]]},"published-print":{"date-parts":[[2024,7,19]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciae169","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,7,15]]},"published":{"date-parts":[[2024,3,26]]}}}